RA CAPITAL MANAGEMENT, L.P. purchased 0.1% of their position (6.39K shares) of HEMAB THERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $159.0K — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/14/2026ACC: 0001231919-26-000495
Director10% Owner
Since Apr 2026
+6.39K
Net shares
Net buyer
$159.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
6.39K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+6.39K
Price / share
$24.90
Trade value
$159.04K
% of position
0.1%
5/12/2026
6.37M→6.37M
Total
Net shares
+6.39K
Net value
$159.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/12/2026 | P · Purchase | +6.39K | $24.90 | $159.04K | 0.1% | 6.37M | 6.37M |
| Total | +6.39K | $159.04K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.01M
Common Stock
IndirectShares owned354.94K
Total
1.36M indirect1.36M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.01M | Indirect |
| Common Stock | 354.94K | Indirect |
| Total | 1.36M | 1.36M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported